speb/financial-data huggingface dataset:
EXE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 4415000000.00
EXE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 4000000.00
EXE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 659000000.00
EXE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 704000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Share Issued: 238150070.00
EXE income_statement (quarterly, 2025-09-30) — Special Income Charges: -53000000.00
EXE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 12000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 18150000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 18150000000.00
EXE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -10739067.06
EXE income_statement (quarterly, 2025-09-30) — Tax Provision: 139000000.00
EXE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
EXE balance_sheet (quarterly, 2025-09-30) — Total Assets: 27606000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 23160000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Total Debt: 5073000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 18150000000.00
EXE income_statement (quarterly, 2025-09-30) — Total Expenses: 2188000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 9456000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 25365000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6690000000.00
EXE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 725000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 169000000.00
EXE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -53000000.00
EXE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -53000000.00
EXE balance_sheet (quarterly, 2025-09-30) — Working Capital: -525000000.00
EXE income_statement (annual, 2025-12-31) — +Operating Expense: 3427000000.00
EXE income_statement (quarterly, 2025-12-31) — +Operating Expense: 873000000.00
EXE income_statement (annual, 2025-12-31) — +Total Revenue: 12189000000.00
EXE income_statement (quarterly, 2025-12-31) — +Total Revenue: 3340000000.00
EXE balance_sheet (annual, 2025-12-31) — Accounts Payable: 753000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 753000000.00
EXE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1363000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1363000000.00
EXE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -8278000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -8278000000.00
EXE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 13746000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 13746000000.00
EXE income_statement (annual, 2025-12-31) — Basic Average Shares: 237290000.00
EXE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 238476000.00
EXE income_statement (annual, 2025-12-31) — Basic EPS: 7.67
EXE income_statement (quarterly, 2025-12-31) — Basic EPS: 2.32
EXE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 395000000.00
EXE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 691000000.00
EXE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 135000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 135000000.00
EXE cash_flow (annual, 2025-12-31) — Capital Expenditure: -2931000000.00
EXE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -867000000.00
EXE cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -2736000000.00
EXE cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -741000000.00
EXE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 51000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 51000000.00
EXE balance_sheet (annual, 2025-12-31) — Capital Stock: 2000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000000.00
EXE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 616000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 616000000.00
EXE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 616000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 616000000.00
EXE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -765000000.00
EXE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -137000000.00
EXE balance_sheet (annual, 2025-12-31) — Cash Financial: 616000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Cash Financial: 616000000.00
EXE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1515000000.00
EXE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -135000000.00
EXE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2759000000.00
EXE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -816000000.00
EXE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4575000000.00
EXE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 956000000.00
EXE cash_flow (annual, 2025-12-31) — Change In Working Capital: -285000000.00
EXE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -427000000.00
EXE cash_flow (annual, 2025-12-31) — Changes In Cash: 301000000.00
EXE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 5000000.00
EXE balance_sheet (annual, 2025-12-31) — Common Stock: 2000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000000.00
EXE cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -765000000.00
EXE cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -137000000.00
EXE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 18578000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 18578000000.00
EXE cash_flow (annual, 2025-12-31) — Common Stock Payments: -100000000.00
EXE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
EXE income_statement (annual, 2025-12-31) — Cost Of Revenue: 5991000000.00
EXE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1569000000.00
EXE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 450000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 450000000.00
EXE balance_sheet (annual, 2025-12-31) — Current Assets: 2916000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Current Assets: 2916000000.00
EXE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 51000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 51000000.00
EXE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 51000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 51000000.00
EXE balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 264000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 264000000.00
EXE balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 264000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 264000000.00
EXE balance_sheet (annual, 2025-12-31) — Current Liabilities: 2901000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2901000000.00
EXE cash_flow (annual, 2025-12-31) — Deferred Income Tax: 448000000.00
EXE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 128000000.00
EXE cash_flow (annual, 2025-12-31) — Deferred Tax: 448000000.00
EXE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 128000000.00
EXE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2980000000.00
EXE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 759000000.00
EXE balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 1000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 1000000.00
EXE income_statement (annual, 2025-12-31) — Diluted Average Shares: 240370000.00
EXE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 240308000.00
EXE income_statement (annual, 2025-12-31) — Diluted EPS: 7.57
EXE income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.30
EXE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1819000000.00
EXE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 553000000.00
EXE balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 232000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 232000000.00
EXE income_statement (annual, 2025-12-31) — EBIT: 2517000000.00
EXE income_statement (quarterly, 2025-12-31) — EBIT: 746000000.00
EXE income_statement (annual, 2025-12-31) — EBITDA: 5497000000.00
EXE income_statement (quarterly, 2025-12-31) — EBITDA: 1505000000.00
EXE cash_flow (annual, 2025-12-31) — End Cash Position: 696000000.00
EXE cash_flow (quarterly, 2025-12-31) — End Cash Position: 696000000.00
EXE balance_sheet (annual, 2025-12-31) — Financial Assets: 47000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Financial Assets: 47000000.00
EXE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1515000000.00
EXE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -135000000.00
EXE cash_flow (annual, 2025-12-31) — Free Cash Flow: 1644000000.00
EXE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 89000000.00
EXE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -550000000.00
EXE cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -236000000.00
EXE income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -65000000.00
EXE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -68000000.00
EXE income_statement (annual, 2025-12-31) — General And Administrative Expense: 181000000.00
EXE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 49000000.00
EXE balance_sheet (annual, 2025-12-31) — Gross PPE: 32593000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 32593000000.00
EXE income_statement (annual, 2025-12-31) — Gross Profit: 6198000000.00
EXE income_statement (quarterly, 2025-12-31) — Gross Profit: 1771000000.00
EXE balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 264000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 264000000.00
EXE income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 37000000.00
EXE cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 66000000.00
EXE cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: -1000000.00
EXE income_statement (annual, 2025-12-31) — Interest Expense: 235000000.00
EXE income_statement (quarterly, 2025-12-31) — Interest Expense: 59000000.00
EXE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 235000000.00
EXE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 59000000.00
EXE cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 230000000.00
EXE cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 15000000.00
EXE balance_sheet (annual, 2025-12-31) — Interest Payable: 100000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Interest Payable: 100000000.00
EXE balance_sheet (annual, 2025-12-31) — Invested Capital: 23587000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 23587000000.00
EXE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -2759000000.00
EXE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -816000000.00
EXE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 990000000.00
EXE cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 165000000.00
EXE balance_sheet (annual, 2025-12-31) — Land And Improvements: 25000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 25000000.00
EXE balance_sheet (annual, 2025-12-31) — Long Term Debt: 5009000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 5009000000.00
EXE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5009000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5009000000.00
EXE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 990000000.00
EXE cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 165000000.00
EXE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1653000000.00
EXE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -828000000.00
EXE balance_sheet (annual, 2025-12-31) — Long Term Provisions: 688000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 688000000.00
EXE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 163000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 163000000.00
EXE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
EXE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -100000000.00
EXE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
EXE balance_sheet (annual, 2025-12-31) — Net Debt: 4393000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Net Debt: 4393000000.00
EXE income_statement (annual, 2025-12-31) — Net Income: 1819000000.00
EXE income_statement (quarterly, 2025-12-31) — Net Income: 553000000.00
EXE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1819000000.00
EXE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 553000000.00
EXE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1819000000.00
EXE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 553000000.00
EXE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1819000000.00
EXE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 553000000.00
EXE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1819000000.00
EXE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 553000000.00
EXE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1819000000.00
EXE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 553000000.00
EXE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1819000000.00
EXE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 553000000.00
EXE income_statement (annual, 2025-12-31) — Net Interest Income: -235000000.00
EXE income_statement (quarterly, 2025-12-31) — Net Interest Income: -59000000.00
EXE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -14000000.00
EXE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
EXE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -663000000.00
EXE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -663000000.00
EXE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -663000000.00
EXE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -663000000.00
EXE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -235000000.00
EXE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -59000000.00
EXE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -11000000.00
EXE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 663000000.00
EXE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 116000000.00
EXE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
EXE balance_sheet (annual, 2025-12-31) — Net PPE: 24315000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Net PPE: 24315000000.00
EXE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -125000000.00
EXE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -75000000.00
EXE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 18578000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 18578000000.00
EXE balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 168000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 168000000.00
EXE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 975000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 975000000.00
EXE balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 975000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 975000000.00
EXE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 168000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 168000000.00
EXE income_statement (annual, 2025-12-31) — Normalized EBITDA: 5793000000.00
EXE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1658000000.00
EXE income_statement (annual, 2025-12-31) — Normalized Income: 2054912000.00
EXE income_statement (quarterly, 2025-12-31) — Normalized Income: 676157205.24
EXE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 4575000000.00
EXE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 956000000.00
EXE cash_flow (annual, 2025-12-31) — Operating Gains Losses: -489000000.00
EXE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -168000000.00
EXE income_statement (annual, 2025-12-31) — Operating Income: 2771000000.00
EXE income_statement (quarterly, 2025-12-31) — Operating Income: 898000000.00
EXE income_statement (annual, 2025-12-31) — Operating Revenue: 12189000000.00
EXE income_statement (quarterly, 2025-12-31) — Operating Revenue: 3340000000.00
EXE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 239249874.00
EXE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 239249874.00
EXE balance_sheet (annual, 2025-12-31) — Other Current Assets: 357000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 357000000.00
EXE balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 147000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 147000000.00
EXE income_statement (annual, 2025-12-31) — Other Gand A: 181000000.00
EXE income_statement (quarterly, 2025-12-31) — Other Gand A: 49000000.00
EXE income_statement (annual, 2025-12-31) — Other Income Expense: -254000000.00
EXE income_statement (quarterly, 2025-12-31) — Other Income Expense: -152000000.00
EXE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 56000000.00
EXE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 99000000.00
EXE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 841000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 841000000.00
EXE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 135000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 135000000.00
EXE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 42000000.00
EXE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1000000.00
EXE income_statement (annual, 2025-12-31) — Other Operating Expenses: 86000000.00
EXE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 33000000.00
EXE balance_sheet (annual, 2025-12-31) — Other Payable: 972000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Other Payable: 972000000.00
EXE balance_sheet (annual, 2025-12-31) — Other Properties: 186000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Other Properties: 186000000.00
EXE balance_sheet (annual, 2025-12-31) — Other Receivables: 18000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 18000000.00
EXE income_statement (annual, 2025-12-31) — Other Special Charges: -4000000.00
EXE income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
EXE balance_sheet (annual, 2025-12-31) — Payables: 1882000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Payables: 1882000000.00
EXE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2332000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2332000000.00
EXE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 107000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 107000000.00
EXE income_statement (annual, 2025-12-31) — Pretax Income: 2282000000.00
EXE income_statement (quarterly, 2025-12-31) — Pretax Income: 687000000.00
EXE cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 24000000.00
EXE cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 2000000.00
EXE cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
EXE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -14000000.00
EXE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
EXE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -195000000.00
EXE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -126000000.00
EXE balance_sheet (annual, 2025-12-31) — Receivables: 1599000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Receivables: 1599000000.00
EXE balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -14000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -14000000.00
EXE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 5991000000.00
EXE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1569000000.00
EXE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2980000000.00
EXE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 759000000.00
EXE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1653000000.00
EXE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -828000000.00
EXE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -100000000.00
EXE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
EXE balance_sheet (annual, 2025-12-31) — Restricted Cash: 80000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 80000000.00
EXE income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 198000000.00
EXE income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 48000000.00
EXE balance_sheet (annual, 2025-12-31) — Retained Earnings: 4830000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 4830000000.00
EXE cash_flow (annual, 2025-12-31) — Sale Of PPE: 70000000.00
EXE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 51000000.00
EXE income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 3160000000.00
EXE income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 791000000.00
EXE income_statement (annual, 2025-12-31) — Selling General And Administration: 3341000000.00
EXE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 840000000.00
EXE balance_sheet (annual, 2025-12-31) — Share Issued: 239249874.00
EXE balance_sheet (quarterly, 2025-12-31) — Share Issued: 239249874.00
EXE income_statement (annual, 2025-12-31) — Special Income Charges: -296000000.00
EXE income_statement (quarterly, 2025-12-31) — Special Income Charges: -153000000.00
EXE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 46000000.00
EXE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 12000000.00
EXE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 18578000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 18578000000.00
EXE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 18578000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 18578000000.00
EXE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -60088000.00
EXE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -29842794.76
EXE income_statement (annual, 2025-12-31) — Tax Provision: 463000000.00
EXE income_statement (quarterly, 2025-12-31) — Tax Provision: 134000000.00
EXE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
EXE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
EXE balance_sheet (annual, 2025-12-31) — Total Assets: 28287000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Total Assets: 28287000000.00
EXE balance_sheet (annual, 2025-12-31) — Total Capitalization: 23587000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 23587000000.00
EXE balance_sheet (annual, 2025-12-31) — Total Debt: 5060000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Total Debt: 5060000000.00
EXE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 18578000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 18578000000.00
EXE income_statement (annual, 2025-12-31) — Total Expenses: 9418000000.00
EXE income_statement (quarterly, 2025-12-31) — Total Expenses: 2442000000.00
EXE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 9709000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 9709000000.00
EXE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 25371000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 25371000000.00
EXE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6808000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6808000000.00
EXE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 2471000000.00
EXE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 745000000.00
EXE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 157000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 157000000.00
EXE income_statement (annual, 2025-12-31) — Total Unusual Items: -296000000.00
EXE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -153000000.00
EXE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -296000000.00
EXE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -153000000.00
EXE balance_sheet (annual, 2025-12-31) — Working Capital: 15000000.00
EXE balance_sheet (quarterly, 2025-12-31) — Working Capital: 15000000.00
EXE income_statement (quarterly, 2026-03-31) — +Operating Expense: 1211000000.00
EXE income_statement (quarterly, 2026-03-31) — +Total Revenue: 4398000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 881000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 957000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -8978000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 13759000000.00
EXE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 239900000.00
EXE income_statement (quarterly, 2026-03-31) — Basic EPS: 4.83
EXE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 696000000.00
EXE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -711000000.00
EXE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -707000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 51000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2220000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2220000000.00
EXE cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -141000000.00
EXE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -192000000.00
EXE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -601000000.00
EXE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 2402000000.00
EXE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 454000000.00
EXE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1609000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Common Stock: 2000000.00
EXE cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -141000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 19546000000.00
EXE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -66000000.00
EXE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1586000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 391000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Current Assets: 4387000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 51000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Current Debt: 875000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 926000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 262000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 262000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3950000000.00
EXE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 319000000.00
EXE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 319000000.00
EXE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 711000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 0.00
EXE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 240759000.00
EXE income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.81
EXE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1159000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 255000000.00
EXE income_statement (quarterly, 2026-03-31) — EBIT: 1548000000.00
EXE income_statement (quarterly, 2026-03-31) — EBITDA: 2259000000.00
EXE cash_flow (quarterly, 2026-03-31) — End Cash Position: 2305000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Financial Assets: 127000000.00
EXE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -192000000.00
EXE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1691000000.00
EXE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 129000000.00
EXE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: -1000000.00
EXE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 63000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 33293000000.00
EXE income_statement (quarterly, 2026-03-31) — Gross Profit: 2812000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 429000000.00
EXE cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 3000000.00
EXE income_statement (quarterly, 2026-03-31) — Interest Expense: 59000000.00
EXE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 59000000.00
EXE cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 100000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Interest Payable: 59000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 24554000000.00
EXE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -601000000.00
EXE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
EXE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4133000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4133000000.00
EXE cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
EXE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
EXE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 703000000.00
EXE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -66000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Net Debt: 2788000000.00
EXE income_statement (quarterly, 2026-03-31) — Net Income: 1159000000.00
EXE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1159000000.00
EXE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1159000000.00
EXE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1159000000.00
EXE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1159000000.00
EXE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1159000000.00
EXE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1159000000.00
EXE income_statement (quarterly, 2026-03-31) — Net Interest Income: -59000000.00
EXE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 9000000.00
EXE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
EXE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
EXE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -59000000.00
EXE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 60000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Net PPE: 24315000000.00
EXE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 37000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 19546000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 0.00
EXE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 911000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 911000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
EXE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2329000000.00
EXE income_statement (quarterly, 2026-03-31) — Normalized Income: 1213530000.00
EXE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 2402000000.00
EXE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 130000000.00
EXE income_statement (quarterly, 2026-03-31) — Operating Income: 1601000000.00
EXE income_statement (quarterly, 2026-03-31) — Operating Revenue: 4398000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 240085572.00
EXE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 363000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 875000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 133000000.00
EXE income_statement (quarterly, 2026-03-31) — Other Gand A: 63000000.00
EXE income_statement (quarterly, 2026-03-31) — Other Income Expense: -53000000.00
EXE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -381000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 692000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 278000000.00
EXE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 17000000.00
EXE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 27000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Other Payable: 1156000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Other Properties: 528000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 92000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Payables: 2183000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2574000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 55000000.00
EXE income_statement (quarterly, 2026-03-31) — Pretax Income: 1489000000.00
EXE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 15000000.00
EXE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -1000000.00
EXE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Receivables: 1290000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -14000000.00
EXE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1586000000.00
EXE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 711000000.00
EXE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
EXE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -66000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 85000000.00
EXE income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 69000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 5785000000.00
EXE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 10000000.00
EXE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 41000000.00
EXE income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1121000000.00
EXE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1184000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Share Issued: 240085572.00
EXE income_statement (quarterly, 2026-03-31) — Special Income Charges: -70000000.00
EXE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 10000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 19546000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 19546000000.00
EXE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -15470000.00
EXE income_statement (quarterly, 2026-03-31) — Tax Provision: 330000000.00
EXE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
EXE balance_sheet (quarterly, 2026-03-31) — Total Assets: 29521000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 23679000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Total Debt: 5059000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 19546000000.00
EXE income_statement (quarterly, 2026-03-31) — Total Expenses: 2797000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 9975000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 25134000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6025000000.00
EXE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 1531000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 146000000.00
EXE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -70000000.00
EXE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -70000000.00
EXE balance_sheet (quarterly, 2026-03-31) — Working Capital: 437000000.00
EXE.PA balance_sheet (annual, 2021-09-30) — Current Deferred Assets: 4529000.00
EXE.PA cash_flow (annual, 2021-09-30) — Net Other Investing Changes: -3602000.00
EXE.PA balance_sheet (annual, 2021-09-30) — Other Non Current Liabilities: 1000.00
EXE.PA income_statement (annual, 2022-09-30) — +Operating Expense: 405170000.00
EXE.PA income_statement (annual, 2022-09-30) — +Total Revenue: 977035000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Accounts Payable: 71014000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Accounts Receivable: 167197000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -316046000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Allowance For Doubtful Accounts Receivable: -6306000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Available For Sale Securities: 3316000.00
EXE.PA income_statement (annual, 2022-09-30) — Basic Average Shares: 6804286.00
EXE.PA income_statement (annual, 2022-09-30) — Basic EPS: 4.20
EXE.PA cash_flow (annual, 2022-09-30) — Beginning Cash Position: 70125000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 74658000.00
EXE.PA cash_flow (annual, 2022-09-30) — Capital Expenditure: -26960000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Capital Lease Obligations: 18545000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Capital Stock: 16970000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 65520000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 65520000.00
EXE.PA cash_flow (annual, 2022-09-30) — Cash Dividends Paid: -10860000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Cash Equivalents: 3000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Cash Financial: 65517000.00
EXE.PA cash_flow (annual, 2022-09-30) — Change In Inventory: -32113000.00
EXE.PA cash_flow (annual, 2022-09-30) — Change In Other Current Assets: -8062000.00
EXE.PA cash_flow (annual, 2022-09-30) — Change In Other Current Liabilities: 524000.00
EXE.PA cash_flow (annual, 2022-09-30) — Change In Payable: -21636000.00
EXE.PA cash_flow (annual, 2022-09-30) — Change In Prepaid Assets: -1393000.00
EXE.PA cash_flow (annual, 2022-09-30) — Change In Receivables: -29254000.00
EXE.PA cash_flow (annual, 2022-09-30) — Change In Working Capital: -91934000.00
EXE.PA cash_flow (annual, 2022-09-30) — Changes In Cash: -11517000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Common Stock: 16970000.00
EXE.PA cash_flow (annual, 2022-09-30) — Common Stock Dividend Paid: -10860000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Common Stock Equity: 419645000.00
EXE.PA cash_flow (annual, 2022-09-30) — Common Stock Issuance: 0.00
EXE.PA cash_flow (annual, 2022-09-30) — Common Stock Payments: -160000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Construction In Progress: 7979000.00
EXE.PA income_statement (annual, 2022-09-30) — Cost Of Revenue: 529775000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Current Assets: 591151000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Current Capital Lease Obligation: 3590000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Current Debt: 128684000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Current Debt And Capital Lease Obligation: 128684000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Current Deferred Assets: 5962000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Current Liabilities: 348802000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Current Provisions: 18948000.00
EXE.PA cash_flow (annual, 2022-09-30) — Deferred Tax: 1810000.00
EXE.PA cash_flow (annual, 2022-09-30) — Depreciation: 26272000.00
EXE.PA cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 26272000.00
EXE.PA income_statement (annual, 2022-09-30) — Depreciation And Amortization In Income Statement: 26265000.00
EXE.PA income_statement (annual, 2022-09-30) — Depreciation Income Statement: 26265000.00
EXE.PA income_statement (annual, 2022-09-30) — Diluted Average Shares: 6804286.00
EXE.PA income_statement (annual, 2022-09-30) — Diluted EPS: 4.20
EXE.PA income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: 28578000.00
EXE.PA income_statement (annual, 2022-09-30) — EBIT: 41212000.00
EXE.PA income_statement (annual, 2022-09-30) — EBITDA: 67484000.00
EXE.PA cash_flow (annual, 2022-09-30) — Effect Of Exchange Rate Changes: 4281000.00
EXE.PA cash_flow (annual, 2022-09-30) — End Cash Position: 62889000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Financial Assets: 0.00
EXE.PA cash_flow (annual, 2022-09-30) — Financing Cash Flow: 85445000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Finished Goods: 55514000.00
EXE.PA cash_flow (annual, 2022-09-30) — Free Cash Flow: -68839000.00
EXE.PA cash_flow (annual, 2022-09-30) — Gain Loss On Sale Of PPE: -142000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Goodwill: 70701000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 98811000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Gross Accounts Receivable: 173504000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Gross PPE: 175130000.00
EXE.PA income_statement (annual, 2022-09-30) — Gross Profit: 447260000.00
EXE.PA income_statement (annual, 2022-09-30) — Interest Expense: 4619000.00
EXE.PA income_statement (annual, 2022-09-30) — Interest Expense Non Operating: 4619000.00
EXE.PA income_statement (annual, 2022-09-30) — Interest Income: 614000.00
EXE.PA income_statement (annual, 2022-09-30) — Interest Income Non Operating: 614000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Inventory: 304364000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Invested Capital: 419645000.00
EXE.PA cash_flow (annual, 2022-09-30) — Investing Cash Flow: -55083000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Investmentin Financial Assets: 3316000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Investmentsin Associatesat Cost: 3760000.00
EXE.PA cash_flow (annual, 2022-09-30) — Issuance Of Capital Stock: 0.00
EXE.PA cash_flow (annual, 2022-09-30) — Issuance Of Debt: 133187000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Land And Improvements: 48927000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Long Term Capital Lease Obligation: 14955000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Long Term Debt: 82447000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 97402000.00
EXE.PA cash_flow (annual, 2022-09-30) — Long Term Debt Issuance: 133187000.00
EXE.PA cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -30236000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Long Term Equity Investment: 3760000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Long Term Provisions: 6140000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Minority Interest: 15000.00
EXE.PA income_statement (annual, 2022-09-30) — Minority Interests: -3000.00
EXE.PA cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: -160000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Net Debt: 63164000.00
EXE.PA income_statement (annual, 2022-09-30) — Net Income: 28578000.00
EXE.PA income_statement (annual, 2022-09-30) — Net Income Common Stockholders: 28578000.00
EXE.PA income_statement (annual, 2022-09-30) — Net Income Continuous Operations: 28582000.00
EXE.PA income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: 28578000.00
EXE.PA income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: 28578000.00
EXE.PA cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: 28578000.00
EXE.PA income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: 28582000.00
EXE.PA income_statement (annual, 2022-09-30) — Net Interest Income: -4005000.00
EXE.PA cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: 102951000.00
EXE.PA cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: 102951000.00
EXE.PA income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: -4005000.00
EXE.PA cash_flow (annual, 2022-09-30) — Net Other Investing Changes: -29905000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Net PPE: 175130000.00
EXE.PA cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: -25178000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 320834000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Assets: 21131000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Liabilities: 9063000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 12267000.00
EXE.PA income_statement (annual, 2022-09-30) — Normalized EBITDA: 73999000.00
EXE.PA income_statement (annual, 2022-09-30) — Normalized Income: 33568490.00
EXE.PA cash_flow (annual, 2022-09-30) — Operating Cash Flow: -41879000.00
EXE.PA income_statement (annual, 2022-09-30) — Operating Income: 42090000.00
EXE.PA income_statement (annual, 2022-09-30) — Operating Revenue: 977035000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 6782437.00
EXE.PA balance_sheet (annual, 2022-09-30) — Other Current Assets: -1000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Other Current Liabilities: 48633000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Other Intangible Assets: 28110000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Other Non Current Assets: 1000.00
EXE.PA income_statement (annual, 2022-09-30) — Other Operating Expenses: 135325000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Other Properties: 43566000.00
EXE.PA balance_sheet (annual, 2022-09-30) — Other Receivables: 20787000.00